Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40012028
Localisation
Finland
Europe
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
26/09/2024
Statut
Classification
1.5°C
Année cible
2030
Orion Corporation commits to reduce absolute scope 1 and 2 GHG emissions 70% by 2030 from a 2023 base year. Orion Corporation also commits that 78% of its suppliers by emissions covering purchased goods and services, capital goods and upstream transportation and distribution will have science-based targets by 2029.
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
ISIN
FI0009014369
LEI
74370029VAHCXDR7B745
Source : Science Based Targets initiative | Données publiques